NDC 39822-0260 – Cyclophosphamide
Cyclophosphamide 2 g/100mL · Injection, Powder, Lyophilized, For Solution · Intravenous, Oral
Product NDC39822-0260
Product details
- Brand name
- Cyclophosphamide
- Generic name
- Cyclophosphamide
- Labeler
- XGen Pharmaceuticals DJB, Inc.
- Dosage form
- Injection, Powder, Lyophilized, For Solution
- Route
- Intravenous, Oral
- Marketing category
- ANDA · ANDA211757
- Marketed since
- December 19, 2023
- Listing expires
- December 31, 2026
Active ingredients
- Cyclophosphamide 2 g/100mL
Uses, dosage, side effects and warnings for Cyclophosphamide →
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 39822-0260-1 | 1 VIAL, SINGLE-DOSE in 1 CARTON (39822-0260-1) / 100 mL in 1 VIAL, SINGLE-DOSE | Dec 19, 2023 |
Other Cyclophosphamide products
- 25021-247 Cyclophosphamide 500 mg/25mL · Injection, Powder, Lyophilized, For Solution · Sagent Pharmaceuticals
- 25021-248 Cyclophosphamide 1 g/50mL · Injection, Powder, Lyophilized, For Solution · Sagent Pharmaceuticals
- 25021-249 Cyclophosphamide 2 g/100mL · Injection, Powder, Lyophilized, For Solution · Sagent Pharmaceuticals
- 39822-0250 Cyclophosphamide 500 mg/25mL · Injection, Powder, Lyophilized, For Solution · XGen Pharmaceuticals DJB, Inc.
- 39822-0255 Cyclophosphamide 1 g/50mL · Injection, Powder, Lyophilized, For Solution · XGen Pharmaceuticals DJB, Inc.
- 62332-619 Cyclophosphamide 50 mg/1 · Capsule · Alembic Pharmaceuticals Inc.
- 62332-618 Cyclophosphamide 25 mg/1 · Capsule · Alembic Pharmaceuticals Inc.
- 46708-618 Cyclophosphamide 25 mg/1 · Capsule · Alembic Pharmaceuticals Limited
- 46708-619 Cyclophosphamide 50 mg/1 · Capsule · Alembic Pharmaceuticals Limited
- 70121-1239 Cyclophosphamide 1 g/50mL · Injection, Powder, For Solution · Amneal Pharmaceuticals LLC
- 70121-1240 Cyclophosphamide 2 g/100mL · Injection, Powder, For Solution · Amneal Pharmaceuticals LLC
- 70121-1238 Cyclophosphamide 500 mg/25mL · Injection, Powder, For Solution · Amneal Pharmaceuticals LLC